← Back to Search

Behavioral Intervention

ATTACH™ Virtual Parenting Program for Children's Mental Health (ATTACH™ Trial)

Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Screening 3 weeks
Treatment Varies
Follow Up change from baseline pcits scores after completion of intervention (an average of 10 weeks).
Awards & highlights


This trial is testing whether a virtual program can improve children's mental, emotional, and behavioral health by helping their parents manage stressors such as depression, addiction, and poverty. The program was originally designed for in-person delivery, but had to be adapted for online delivery due to the COVID-19 pandemic.

Who is the study for?
This trial is for parents with children aged between birth and 32 months who are willing to participate in a 10-12 week parenting program. They must commit to one-hour weekly sessions, involve a co-parent for some sessions if possible, and consent to dried blood sample collection from themselves and their children at Calgary agencies.Check my eligibility
What is being tested?
The ATTACH™ Parenting Program is being adapted for online delivery due to COVID-19. The study will develop web-based applications and mobile apps aimed at improving the mental, emotional, and behavioral health of children by supporting parents through virtual training.See study design
What are the potential side effects?
Since this intervention involves educational support rather than medical treatment, traditional side effects are not applicable. However, participants may experience discomfort or stress related to technology use or confronting personal issues during the program.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline pcits scores after completion of intervention (an average of 10 weeks).
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline pcits scores after completion of intervention (an average of 10 weeks). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mother Child interaction Quality will be assessed by Parent Child Interaction Teaching Scale (PCITS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
A quasi-experimental design was selected to more closely approximate service delivery models in agencies that do not typically employ control groups. Given promising findings (from seven ATTACH™ pilot studies), a randomized controlled trial design, even employing wait-list controls was deemed unacceptable and even unethical by patients, health care professionals and health system administrators in engagement activities surrounding the preparation of this proposal.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
800 Previous Clinical Trials
875,070 Total Patients Enrolled
31 Trials studying Depression
10,540 Patients Enrolled for Depression

Media Library

ATTACH™ Parenting Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04857775 — N/A
Depression Research Study Groups: Intervention group
Depression Clinical Trial 2023: ATTACH™ Parenting Program Highlights & Side Effects. Trial Name: NCT04857775 — N/A
ATTACH™ Parenting Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04857775 — N/A
~51 spots leftby Dec 2027